{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:15:08Z","timestamp":1794021308238,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL161070"],"award-info":[{"award-number":["HL161070"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL167195"],"award-info":[{"award-number":["HL167195"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL167195"],"award-info":[{"award-number":["HL167195"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL055438"],"award-info":[{"award-number":["HL055438"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL170144"],"award-info":[{"award-number":["HL170144"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-025-00693-3","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:13:38Z","timestamp":1755011618000},"page":"976-990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preventing the phosphorylation of RyR2 at canonical sites reduces Ca2+ leak and promotes arrhythmia by reactivating the INa current"],"prefix":"10.1038","volume":"4","author":[{"given":"Jingjing","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ponce-Balbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick B.","family":"R\u00edos P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly C.","family":"Dooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor H.","family":"Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-9029","authenticated-orcid":false,"given":"Francisco J.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"693_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/oxfordjournals.jbchem.a123735","volume":"111","author":"A Yoshida","year":"1992","unstructured":"Yoshida, A. et al. Phosphorylation of ryanodine receptors in rat myocytes during \u03b2-adrenergic stimulation. J. Biochem. 111, 186\u2013190 (1992).","journal-title":"J. Biochem."},{"key":"693_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fphar.2014.00101","volume":"5","author":"E Camors","year":"2014","unstructured":"Camors, E. & Valdivia, H. H. CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors. Front. Pharmacol. 5, 101 (2014).","journal-title":"Front. Pharmacol."},{"key":"693_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbrc.2008.08.084","volume":"376","author":"S Huke","year":"2008","unstructured":"Huke, S. & Bers, D. M. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 376, 80\u201385 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"693_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41569-020-00443-x","volume":"17","author":"FJ Alvarado","year":"2020","unstructured":"Alvarado, F. J. & Valdivia, H. H. Mechanisms of ryanodine receptor 2 dysfunction in heart failure. Nat. Rev. Cardiol. 17, 748 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"693_CR5","doi-asserted-by":"crossref","unstructured":"Houser, S. R. Role of RyR2 phosphorylation in heart failure and arrhythmias: protein kinase A\u2013mediated hyperphosphorylation of the ryanodine receptor at serine 2808 does not alter cardiac contractility or cause heart failure and arrhythmias. Circ. Res. 114, 1320\u20131327; discussion 1327 (2014).","DOI":"10.1161\/CIRCRESAHA.114.300569"},{"key":"693_CR6","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1172\/JCI32726","volume":"120","author":"J Shan","year":"2010","unstructured":"Shan, J. et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J. Clin. Invest. 120, 4388\u20134398 (2010).","journal-title":"J. Clin. Invest."},{"key":"693_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1073\/pnas.0510113103","volume":"103","author":"XH Wehrens","year":"2006","unstructured":"Wehrens, X. H. et al. Ryanodine receptor\/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc. Natl Acad. Sci. USA 103, 511\u2013518 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR8","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/CIRCRESAHA.108.174722","volume":"102","author":"SM MacDonnell","year":"2008","unstructured":"MacDonnell, S. M. et al. Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circ. Res. 102, e65\u2013e72 (2008).","journal-title":"Circ. Res."},{"key":"693_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.yjmcc.2017.01.001","volume":"103","author":"FJ Alvarado","year":"2017","unstructured":"Alvarado, F. J., Chen, X. & Valdivia, H. H. Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable. J. Mol. Cell. Cardiol. 103, 40\u201347 (2017).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"693_CR10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","volume":"97","author":"X Ai","year":"2005","unstructured":"Ai, X., Curran, J. W., Shannon, T. R., Bers, D. M. & Pogwizd, S. M. Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ. Res. 97, 1314\u20131322 (2005).","journal-title":"Circ. Res."},{"key":"693_CR11","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1161\/01.RES.0000125626.33738.E2","volume":"94","author":"XH Wehrens","year":"2004","unstructured":"Wehrens, X. H., Lehnart, S. E., Reiken, S. R. & Marks, A. R. Ca2+\/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 94, e61\u2013e70 (2004).","journal-title":"Circ. Res."},{"key":"693_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/CIRCRESAHA.112.268094","volume":"110","author":"JL Respress","year":"2012","unstructured":"Respress, J. L. et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474\u20131483 (2012).","journal-title":"Circ. Res."},{"key":"693_CR13","doi-asserted-by":"crossref","unstructured":"Janicek, R. et al. Dual ablation of the RyR2-Ser2808 and RyR2-Ser2814 sites increases propensity for pro-arrhythmic spontaneous Ca2+ releases. J. Physiol. 602, 5179\u20135201 (2024).","DOI":"10.1113\/JP286453"},{"key":"693_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41569-020-00444-w","volume":"17","author":"H Dridi","year":"2020","unstructured":"Dridi, H. et al. Reply to \u2018Mechanisms of ryanodine receptor 2 dysfunction in heart failure\u2019. Nat. Rev. Cardiol. 17, 749\u2013750 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"693_CR15","doi-asserted-by":"publisher","first-page":"eabo1272","DOI":"10.1126\/sciadv.abo1272","volume":"8","author":"MC Miotto","year":"2022","unstructured":"Miotto, M. C. et al. Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Sci. Adv. 8, eabo1272 (2022).","journal-title":"Sci. Adv."},{"key":"693_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCRESAHA.107.153007","volume":"101","author":"NA Benkusky","year":"2007","unstructured":"Benkusky, N. A. et al. Intact \u03b2-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ. Res. 101, 819\u2013829 (2007).","journal-title":"Circ. Res."},{"key":"693_CR17","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCRESAHA.118.313417","volume":"124","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Cardiomyocyte PKA ablation enhances basal contractility while eliminates cardiac \u03b2-adrenergic response without adverse effects on the heart. Circ. Res. 124, 1760\u20131777 (2019).","journal-title":"Circ. Res."},{"key":"693_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.RES.0000163276.26083.e8","volume":"96","author":"B Xiao","year":"2005","unstructured":"Xiao, B. et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ. Res. 96, 847\u2013855 (2005).","journal-title":"Circ. Res."},{"key":"693_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1085\/jgp.201812155","volume":"151","author":"DM Potenza","year":"2019","unstructured":"Potenza, D. M. et al. Phosphorylation of the ryanodine receptor 2 at serine 2030 is required for a complete \u03b2-adrenergic response. J. Gen. Physiol. 151, 131\u2013145 (2019).","journal-title":"J. Gen. Physiol."},{"key":"693_CR20","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCRESAHA.112.270876","volume":"110","author":"HH Valdivia","year":"2012","unstructured":"Valdivia, H. H. Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and \u2018criminalizing\u2019 S2814. Circ. Res. 110, 1398\u20131402 (2012).","journal-title":"Circ. Res."},{"key":"693_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.RES.0000036914.12686.28","volume":"91","author":"TR Shannon","year":"2002","unstructured":"Shannon, T. R., Ginsburg, K. S. & Bers, D. M. Quantitative assessment of the SR Ca2+ leak\u2013load relationship. Circ. Res. 91, 594\u2013600 (2002).","journal-title":"Circ. Res."},{"key":"693_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.RES.0000093399.11734.B3","volume":"93","author":"TR Shannon","year":"2003","unstructured":"Shannon, T. R., Pogwizd, S. M. & Bers, D. M. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ. Res. 93, 592\u2013594 (2003).","journal-title":"Circ. Res."},{"key":"693_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1085\/jgp.201812269","volume":"151","author":"MM Lopez Alarcon","year":"2019","unstructured":"Lopez Alarcon, M. M., Rodriguez de Yurre, A., Felice, J. I., Medei, E. & Escobar, A. L. Phase 1 repolarization rate defines Ca2+ dynamics and contractility on intact mouse hearts. J. Gen. Physiol. 151, 771\u2013785 (2019).","journal-title":"J. Gen. Physiol."},{"key":"693_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1085\/jgp.108.5.435","volume":"108","author":"S Adachi-Akahane","year":"1996","unstructured":"Adachi-Akahane, S., Cleemann, L. & Morad, M. Cross-signaling between L-type Ca2+ channels and ryanodine receptors in rat ventricular myocytes. J. Gen. Physiol. 108, 435\u2013454 (1996).","journal-title":"J. Gen. Physiol."},{"key":"693_CR25","doi-asserted-by":"crossref","unstructured":"Bers, D. M. Excitation-Contraction Coupling and Cardiac Contractile Force (Kluwer Academic Publishers, 2001).","DOI":"10.1007\/978-94-010-0658-3"},{"key":"693_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCEP.113.001666","volume":"7","author":"AG Edwards","year":"2014","unstructured":"Edwards, A. G. et al. Nonequilibrium reactivation of Na+ current drives early afterdepolarizations in mouse ventricle. Circ. Arrhythm. Electrophysiol. 7, 1205\u20131213 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"693_CR27","doi-asserted-by":"publisher","first-page":"e008638","DOI":"10.1161\/CIRCEP.120.008638","volume":"13","author":"L Reilly","year":"2020","unstructured":"Reilly, L. et al. Genetic loss of IK1 causes adrenergic-induced phase 3 early afterdepolarizations and polymorphic and bidirectional ventricular tachycardia. Circ. Arrhythm. Electrophysiol. 13, e008638 (2020).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"693_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.hrthm.2012.12.035","volume":"10","author":"H Watanabe","year":"2013","unstructured":"Watanabe, H. et al. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 10, 542\u2013547 (2013).","journal-title":"Heart Rhythm"},{"key":"693_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCEP.110.959916","volume":"4","author":"HS Hwang","year":"2011","unstructured":"Hwang, H. S. et al. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ. Arrhythm. Electrophysiol. 4, 128\u2013135 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"693_CR30","doi-asserted-by":"publisher","first-page":"108a","DOI":"10.1016\/j.bpj.2013.11.665","volume":"106","author":"E Camors","year":"2014","unstructured":"Camors, E. et al. Preventing RyR2-S2808 and RyR2-S2814 phosphorylation does not alter the \u03b2-adrenergic response of mouse hearts. Biophys. J. 106, 108a (2014).","journal-title":"Biophys. J."},{"key":"693_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-020-1947-z","volume":"577","author":"G Liu","year":"2020","unstructured":"Liu, G. et al. Mechanism of adrenergic CaV1.2 stimulation revealed by proximity proteomics. Nature 577, 695\u2013700 (2020).","journal-title":"Nature"},{"key":"693_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers, D. M. Cardiac excitation\u2013contraction coupling. Nature 415, 198\u2013205 (2002).","journal-title":"Nature"},{"key":"693_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jmb.2014.08.004","volume":"427","author":"F Van Petegem","year":"2015","unstructured":"Van Petegem, F. Ryanodine receptors: allosteric ion channel giants. J. Mol. Biol. 427, 31\u201353 (2015).","journal-title":"J. Mol. Biol."},{"key":"693_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1113\/jphysiol.2003.055384","volume":"556","author":"KS Ginsburg","year":"2004","unstructured":"Ginsburg, K. S. & Bers, D. M. Modulation of excitation\u2013contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger. J. Physiol. 556, 463\u2013480 (2004).","journal-title":"J. Physiol."},{"key":"693_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1113\/jphysiol.2009.181800","volume":"588","author":"J Ogrodnik","year":"2010","unstructured":"Ogrodnik, J. & Niggli, E. Increased Ca2+ leak and spatiotemporal coherence of Ca2+ release in cardiomyocytes during \u03b2-adrenergic stimulation. J. Physiol. 588, 225\u2013242 (2010).","journal-title":"J. Physiol."},{"key":"693_CR36","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/hh0801.090461","volume":"88","author":"LS Song","year":"2001","unstructured":"Song, L. S. et al. \u03b2-Adrenergic stimulation synchronizes intracellular Ca2+ release during excitation-contraction coupling in cardiac myocytes. Circ. Res. 88, 794\u2013801 (2001).","journal-title":"Circ. Res."},{"key":"693_CR37","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1161\/CIRCRESAHA.122.321177","volume":"132","author":"J Wei","year":"2023","unstructured":"Wei, J. et al. RyR2 serine-2030 PKA site governs Ca2+ release termination and Ca2+ alternans. Circ. Res. 132, e59\u2013e77 (2023).","journal-title":"Circ. Res."},{"key":"693_CR38","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/CIRCULATIONAHA.110.982298","volume":"122","author":"RJ van Oort","year":"2010","unstructured":"van Oort, R. J. et al. Ryanodine receptor phosphorylation by calcium\/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 122, 2669\u20132679 (2010).","journal-title":"Circulation"},{"key":"693_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1113\/jphysiol.1995.sp020904","volume":"487","author":"AJ Lokuta","year":"1995","unstructured":"Lokuta, A. J., Rogers, T. B., Lederer, W. J. & Valdivia, H. H. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism. J. Physiol. 487, 609\u2013622 (1995).","journal-title":"J. Physiol."},{"key":"693_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1113\/JP278951","volume":"598","author":"DM Potenza","year":"2020","unstructured":"Potenza, D. M., Janicek, R., Fernandez-Tenorio, M. & Niggli, E. Activation of endogenous protein phosphatase 1 enhances the calcium sensitivity of the ryanodine receptor type 2 in murine ventricular cardiomyocytes. J. Physiol. 598, 1131\u20131150 (2020).","journal-title":"J. Physiol."},{"key":"693_CR41","doi-asserted-by":"publisher","first-page":"541a","DOI":"10.1016\/j.bpj.2016.11.2925","volume":"112","author":"DM Potenza","year":"2017","unstructured":"Potenza, D. M., Janicek, R., Fernandez-Tenorio, M., Valdivia, H. H. & Niggli, E. Ablation of the RyR2-Ser2030 phosphorylation site limits changes in RyR2 sensitivity during \u03b2-adrenergic stimulation. Biophys. J. 112, 541a\u2013542a (2017).","journal-title":"Biophys. J."},{"key":"693_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yjmcc.2015.06.007","volume":"85","author":"M Grimm","year":"2015","unstructured":"Grimm, M. et al. CaMKII\u03b4 mediates beta-adrenergic effects on RyR2 phosphorylation and SR Ca2+ leak and the pathophysiological response to chronic \u03b2-adrenergic stimulation. J. Mol. Cell. Cardiol. 85, 282\u2013291 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"693_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-physiol-020911-153308","volume":"76","author":"DM Bers","year":"2014","unstructured":"Bers, D. M. Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. Annu. Rev. Physiol. 76, 107\u2013127 (2014).","journal-title":"Annu. Rev. Physiol."},{"key":"693_CR44","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1529\/biophysj.104.047449","volume":"87","author":"TR Shannon","year":"2004","unstructured":"Shannon, T. R., Wang, F., Puglisi, J., Weber, C. & Bers, D. M. A mathematical treatment of integrated Ca dynamics within the ventricular myocyte. Biophys. J. 87, 3351\u20133371 (2004).","journal-title":"Biophys. J."},{"key":"693_CR45","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1113\/jphysiol.2010.202663","volume":"589","author":"K Acsai","year":"2011","unstructured":"Acsai, K., Antoons, G., Livshitz, L., Rudy, Y. & Sipido, K. R. Microdomain [Ca2+] near ryanodine receptors as reported by L-type Ca2+ and Na+\/Ca2+ exchange currents. J. Physiol. 589, 2569\u20132583 (2011).","journal-title":"J. Physiol."},{"key":"693_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0006-3495(98)77776-8","volume":"74","author":"A Peskoff","year":"1998","unstructured":"Peskoff, A. & Langer, G. A. Calcium concentration and movement in the ventricular cardiac cell during an excitation-contraction cycle. Biophys. J. 74, 153\u2013174 (1998).","journal-title":"Biophys. J."},{"key":"693_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCRESAHA.115.303582","volume":"115","author":"S Despa","year":"2014","unstructured":"Despa, S. et al. Junctional cleft [Ca2+]i measurements using novel cleft-targeted Ca2+ sensors. Circ. Res. 115, 339\u2013347 (2014).","journal-title":"Circ. Res."},{"key":"693_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/CIRCRESAHA.114.302938","volume":"114","author":"W Shang","year":"2014","unstructured":"Shang, W. et al. Imaging Ca2+ nanosparks in heart with a new targeted biosensor. Circ. Res. 114, 412\u2013420 (2014).","journal-title":"Circ. Res."},{"key":"693_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nm.1942","volume":"15","author":"H Watanabe","year":"2009","unstructured":"Watanabe, H. et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat. Med. 15, 380\u2013383 (2009).","journal-title":"Nat. Med."},{"key":"693_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1085\/jgp.20028723","volume":"121","author":"H Liu","year":"2003","unstructured":"Liu, H., Atkins, J. & Kass, R. S. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues. J. Gen. Physiol. 121, 199\u2013214 (2003).","journal-title":"J. Gen. Physiol."},{"key":"693_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","volume":"2","author":"PJ Kannankeril","year":"2017","unstructured":"Kannankeril, P. J. et al. Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial. JAMA Cardiol. 2, 759\u2013766 (2017).","journal-title":"JAMA Cardiol."},{"key":"693_CR52","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1073\/pnas.1816685116","volume":"116","author":"SM Batiste","year":"2019","unstructured":"Batiste, S. M. et al. Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic. Proc. Natl Acad. Sci. USA 116, 4810\u20134815 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"693_CR53","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1253\/circj.CJ-10-0680","volume":"74","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi, S. et al. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2R2474S\/+ knock-in mouse model. Circ. J. 74, 2579\u20132584 (2010).","journal-title":"Circ. J."},{"key":"693_CR54","doi-asserted-by":"publisher","first-page":"eaba7287","DOI":"10.1126\/scitranslmed.aba7287","volume":"13","author":"B Sun","year":"2021","unstructured":"Sun, B. et al. Cardiac ryanodine receptor calcium release deficiency syndrome. Sci. Transl. Med. 13, eaba7287 (2021).","journal-title":"Sci. Transl. Med."},{"key":"693_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2022.04.004","volume":"167","author":"J Zheng","year":"2022","unstructured":"Zheng, J. et al. Preserved cardiac performance and adrenergic response in a rabbit model with decreased ryanodine receptor 2 expression. J. Mol. Cell. Cardiol. 167, 118\u2013128 (2022).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"693_CR56","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.str.2023.04.009","volume":"31","author":"S Cholak","year":"2023","unstructured":"Cholak, S. et al. Allosteric modulation of ryanodine receptor RyR1 by nucleotide derivatives. Structure 31, 790\u2013800 (2023).","journal-title":"Structure"},{"key":"693_CR57","doi-asserted-by":"publisher","first-page":"e126544","DOI":"10.1172\/jci.insight.126544","volume":"5","author":"FJ Alvarado","year":"2019","unstructured":"Alvarado, F. J. et al. Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2. JCI Insight 5, e126544 (2019).","journal-title":"JCI Insight"},{"key":"693_CR58","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCRESAHA.112.274803","volume":"112","author":"R Loaiza","year":"2013","unstructured":"Loaiza, R. et al. Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 112, 298\u2013308 (2013).","journal-title":"Circ. Res."},{"key":"693_CR59","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCRESAHA.123.322847","volume":"133","author":"J Tomek","year":"2023","unstructured":"Tomek, J., Nieves-Cintron, M., Navedo, M. F., Ko, C. Y. & Bers, D. M. SparkMaster 2: a new software for automatic analysis of calcium spark data. Circ. Res. 133, 450\u2013462 (2023).","journal-title":"Circ. Res."},{"key":"693_CR60","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1085\/jgp.118.6.653","volume":"118","author":"S Hollingworth","year":"2001","unstructured":"Hollingworth, S., Peet, J., Chandler, W. K. & Baylor, S. M. Calcium sparks in intact skeletal muscle fibers of the frog. J. Gen. Physiol. 118, 653\u2013678 (2001).","journal-title":"J. Gen. Physiol."},{"key":"693_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yjmcc.2009.10.005","volume":"48","author":"FA Hilliard","year":"2010","unstructured":"Hilliard, F. A. et al. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J. Mol. Cell. Cardiol. 48, 293\u2013301 (2010).","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00693-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00693-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00693-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:50:02Z","timestamp":1757346602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00693-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00693-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.08.602617","asserted-by":"object"}]},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}